FOLH1 and neoplasm: Based on our results, the total tumour burden by [68Ga]Ga-PSMA-11 PET/CT (measured as either TLP or MTV) is an important parameter for monitoring PSMA-targeted tandem RLT and may be used to assess other treatments in patients with mCRPC.